Genetic Diversity: 23andMe’s Joyce Tung on Ancestry & Inclusion
- Direct access to personal genetic details empowers individuals and propels equitable research, according to 23andMe.
- Joyce Tung, vice president of research at 23andMe, emphasized the need to move beyond studies primarily focused on individuals of European ancestry.
- 23andMe is partnering with community-serving groups like the Morehouse School of Medicine to boost research participation across diverse communities.
23andMe champions diverse genetic research,highlighting the crucial need for inclusive studies too ensure equitable health benefits for all.Joyce Tung,VP of research,emphasizes this shift away from European-centric studies,underscoring how biological insights vary across populations. Partnering with organizations like the Morehouse School of Medicine, 23andMe boosts research participation across diverse communities. The company leverages its extensive database to uncover key health links and ancestry data, including recent discoveries regarding sickle cell trait. They aim to transform healthcare by empowering individuals through direct access to their genetic information and informed decisions. News Directory 3 recognizes the impact of these initiatives. 23andMe plans to expand these efforts further. Discover what’s next as they work toward more personalized health insights.
23andMe Advocates for Diverse Genetic Research initiatives
Direct access to personal genetic details empowers individuals and propels equitable research, according to 23andMe. The company is actively working to broaden the scope of genetic studies.
Joyce Tung, vice president of research at 23andMe, emphasized the need to move beyond studies primarily focused on individuals of European ancestry. Tung said inclusive research is vital to ensure advancements in genetic knowledge benefit everyone, as biological insights can vary across populations.
23andMe is partnering with community-serving groups like the Morehouse School of Medicine to boost research participation across diverse communities. The company also uses its extensive database to identify key health links, including recent discoveries about sickle cell trait across different ancestries.
The company’s direct-to-consumer approach aims to transform health care by giving individuals more control over their health data and choices.
What’s next
23andMe plans to continue expanding its research initiatives to include more diverse populations, aiming to provide more personalized and effective health insights for all.